Hans Ueli Rihs Family

Source of Wealth: Hearing aids, via ownership stake in Sonova Holding. The company’s global leadership in hearing technology, combined with recurring revenue from product sales and services, forms the foundation of Rihs’s fortune.

Residence: Switzerland. The country’s stable political environment, strong financial sector, and favorable tax treatment for high-net-worth individuals make it a common base for European billionaires.

Citizenship: Switzerland. Dual citizenship is not mentioned in the provided data, so it is assumed he holds only Swiss citizenship.

Marital Status: Married. Family structure is relevant in the context of wealth transfer and succession planning, especially given the family’s long-standing control of Sonova.

Related People & Companies: Beda Diethelm (co-owner of Sonova), Andy Rihs (late brother and co-founder), Sonova Holding (publicly traded), Swiss Casinos AG (private), BSC Young Boys (private sports team). These relationships illustrate a network of family and professional ties that have sustained the business over decades.

Key Risks: Regulatory changes in healthcare (e.g., OTC hearing aids), competition from tech giants entering the space, performance of private holdings (casinos, football club), and succession planning after the death of his brother. The lack of transparency in private assets means investors and analysts must rely on proxies to estimate true net worth.

Legacy: Hans-Ueli Rihs represents a generation of European industrialists who built global companies through patient capital and family governance. His ownership of a football club and casinos adds a cultural dimension to his profile, distinguishing him from purely corporate billionaires. The future of his wealth will depend on how well Sonova adapts to technological disruption and whether his private holdings can maintain their value in a changing economic landscape.

Hans-Ueli Rihs’s net worth is derived primarily from his 6% stake in Sonova Holding AG, a publicly traded company listed on the SIX Swiss Exchange. As of April 2025, Sonova reported nearly $4 billion in fiscal 2024 revenue, positioning it as the world’s largest manufacturer of hearing aids. While the exact valuation of Rihs’s stake fluctuates with Sonova’s stock price, his position as the second-largest individual shareholder implies a substantial equity value. Publicly disclosed rankings place him at #2202 globally, though such rankings are subject to market volatility, currency fluctuations, and reporting methodologies.

Unlike many billionaires whose wealth is concentrated in a single private holding, Rihs’s net worth is partially transparent due to Sonova’s public status. However, his privately held assets—including Swiss Casinos AG and BSC Young Boys—add layers of complexity to any net worth estimate. These assets are not subject to public financial disclosures, meaning their valuation relies on industry benchmarks, comparable transactions, or analyst estimates, none of which are provided in the source material. As such, any net worth figure attributed to Rihs should be treated as an approximation rather than a precise accounting.

It is also worth noting that wealth rankings such as those published by are often based on a combination of public filings, insider estimates, and proprietary modeling. The #2202 global ranking reflects a snapshot in time and may not capture recent market movements or private asset revaluations. Additionally, the inclusion of “family” in his name suggests potential shared ownership or inheritance structures, though the source material does not specify the extent of family involvement in asset control or wealth distribution.

For context, Sonova’s market capitalization as of early 2025 was approximately $15 billion, meaning Rihs’s 6% stake would represent roughly $900 million in equity value, assuming no dilution or complex ownership structures. However, this is a simplified calculation. Real-world valuations must account for voting rights, liquidity discounts, and potential restrictions on share sales. Furthermore, private holdings like Swiss Casinos AG and BSC Young Boys may contribute significantly to his overall net worth, particularly if they have appreciated in value or generate substantial cash flow. Without audited financials or public disclosures for these entities, their contribution remains speculative.

In summary, Hans-Ueli Rihs’s net worth is anchored in his Sonova stake but likely augmented by private holdings. The exact figure is not publicly disclosed in the provided data, and any estimate must acknowledge the limitations of available information. His wealth is tied to the performance of a global healthcare technology company, the regulatory environment for gambling in Switzerland, and the commercial success of a professional soccer team—all of which introduce distinct risk and return profiles.

The wealth trajectory of Hans-Ueli Rihs is inextricably linked to the evolution of Sonova Holding AG, a company his father Ernest Rihs acquired in 1965. At that time, the hearing aid industry was fragmented and technologically nascent, with limited global reach. Ernest’s acquisition laid the foundation for a family enterprise that would later become a global leader. After Ernest’s death in 1980, Hans-Ueli and his brother Andy, alongside fellow billionaire Beda Diethelm, took the reins and transformed Sonova into the world’s largest hearing aid manufacturer. This transition from a regional player to a global powerhouse represents the core of Rihs’s wealth accumulation.

During the 1980s and 1990s, Sonova expanded through strategic acquisitions and technological innovation. The company’s growth was fueled by demographic trends—aging populations in developed markets increased demand for hearing solutions—and by advancements in digital signal processing, which improved product performance and user experience. Rihs and his partners capitalized on these trends, scaling operations across Europe, North America, and Asia. The company’s initial public offering on the SIX Swiss Exchange provided liquidity and access to capital, further accelerating growth. By the early 2000s, Sonova had established itself as a dominant player, with a portfolio of well-known brands and a global distribution network.

The death of Andy Rihs in 2018 marked a significant inflection point. While the source material does not specify the impact on ownership structure or wealth distribution, it is reasonable to assume that Andy’s stake was either inherited by family members or sold, potentially altering Hans-Ueli’s relative position within the company. The continued partnership with Beda Diethelm suggests a stable governance structure, but the loss of a co-founder may have introduced new dynamics in strategic decision-making or asset allocation.

Beyond Sonova, Rihs’s wealth history includes diversification into entertainment and leisure sectors. His ownership of Swiss Casinos AG, which operates four casinos in Switzerland, represents a deliberate expansion into regulated gaming—a sector with high margins but significant regulatory risk. Similarly, his ownership of BSC Young Boys, a Swiss soccer team, reflects an interest in sports and community engagement, though the financial returns from such ventures are often secondary to brand value or personal passion. These assets likely contribute to his overall net worth, but their valuation is opaque due to the lack of public disclosures.

Over time, Rihs’s wealth has been subject to the same market forces that affect all publicly traded equities: stock price volatility, currency fluctuations, and macroeconomic conditions. For example, a downturn in the Swiss franc or a global recession could impact Sonova’s revenue and, by extension, Rihs’s net worth. Conversely, technological breakthroughs in hearing aid design or expansion into emerging markets could drive growth. The source material does not provide historical net worth figures, making it impossible to chart a precise wealth trajectory. However, the consistent growth of Sonova’s revenue—from a small family business to a $4 billion enterprise—suggests a steady accumulation of wealth over decades.

In summary, Hans-Ueli Rihs’s wealth history is characterized by long-term value creation through a family-controlled enterprise, strategic diversification into private holdings, and adaptation to global market trends. His net worth is not the result of a single windfall but of sustained operational excellence, prudent capital allocation, and the ability to navigate industry-specific challenges. The absence of detailed financial data limits a more granular analysis, but the available information paints a picture of a billionaire whose wealth is deeply rooted in the success of a global healthcare technology company.

Beda Diethelm: Fellow billionaire and co-builder of Sonova alongside Hans-Ueli and Andy Rihs. Diethelm’s stake in Sonova is also substantial, and his partnership with the Rihs family has been instrumental in scaling the company globally. Their collaboration exemplifies a rare model of family-business continuity in a highly technical industry.

Bill Austin: American entrepreneur who founded Starkey Hearing Technologies, one of Sonova’s main competitors. Austin’s background in audiology and direct-to-consumer marketing contrasts with Rihs’s more institutional, B2B-focused approach. Both men represent different philosophies in the hearing aid industry — Austin’s is more entrepreneurial and U.S.-centric, while Rihs’s is more corporate and European.

Susan Carol Holland: Italian billionaire and majority shareholder of Amplifon, Europe’s largest hearing aid retailer. Holland’s wealth is derived from distribution rather than manufacturing, making her a downstream player compared to Rihs. Her company’s retail footprint gives her exposure to consumer trends, while Rihs’s manufacturing focus provides control over product innovation and pricing.

These peers highlight the diversity of wealth creation in the hearing aid sector — from manufacturing (Rihs, Austin) to retail (Holland) — and the importance of regional market dynamics. Rihs’s combination of manufacturing, leisure, and sports assets sets him apart from peers who focus on a single industry.

Hans-Ueli Rihs’s early life is not detailed in the provided source material. However, it is known that his father, Ernest Rihs, acquired Sonova in 1965, suggesting that Hans-Ueli was likely exposed to the hearing aid business from a young age. The family’s involvement in the company implies a upbringing shaped by entrepreneurship, manufacturing, and the challenges of running a small business in a specialized industry. Given that Ernest died in 1980, Hans-Ueli and his brother Andy would have been adults by that time, positioning them to assume leadership roles in the company.

While no information is provided about Hans-Ueli’s education, career before Sonova, or personal milestones, it is reasonable to infer that his path was influenced by his father’s legacy. The transition from a family-owned enterprise to a global corporation required a blend of technical expertise, business acumen, and strategic vision—all of which would have been cultivated over time. The absence of details about his early life does not diminish the significance of his later achievements but highlights the limitations of the available data.

It is also worth noting that the source material does not mention any siblings beyond Andy Rihs, nor does it provide information about Hans-Ueli’s children or other family members. This lack of detail makes it difficult to assess the extent of family involvement in his wealth or the potential for intergenerational transfer of assets. However, the reference to “family” in his name suggests that his wealth may be shared or managed collectively, though the specifics are not disclosed.

In summary, Hans-Ueli Rihs’s early life remains largely undocumented in the provided data. What is clear is that his trajectory was shaped by his family’s ownership of Sonova and the opportunity to build on his father’s foundation. His success is a testament to the ability to scale a niche business into a global leader, a feat that required both vision and execution over multiple decades.

Hans-Ueli Rihs’s path to wealth began with the acquisition of Sonova by his father, Ernest Rihs, in 1965. At that time, the company was a small player in the hearing aid industry, a sector characterized by limited technological innovation and regional markets. Ernest’s decision to enter this space laid the groundwork for a family enterprise that would later become a global leader. After Ernest’s death in 1980, Hans-Ueli and his brother Andy, alongside Beda Diethelm, took over the company and embarked on a mission to transform it into a multinational corporation.

Their strategy centered on three pillars: technological innovation, global expansion, and strategic acquisitions. In the 1980s and 1990s, Sonova invested heavily in research and development, pioneering digital hearing aids that offered superior sound quality and user customization. This technological edge allowed the company to differentiate itself from competitors and capture market share in high-growth regions. Simultaneously, Sonova expanded its footprint through acquisitions of regional distributors and manufacturers, building a global supply chain and distribution network.

The company’s initial public offering on the SIX Swiss Exchange provided a critical source of capital and liquidity, enabling further growth and attracting institutional investors. By the early 2000s, Sonova had established itself as the world’s largest hearing aid manufacturer, with a portfolio of well-known brands and a reputation for quality and innovation. Hans-Ueli’s role in this transformation was pivotal, though the source material does not specify his exact responsibilities or contributions. His 6% stake in the company suggests a significant ownership position, likely reflecting his active involvement in strategic decision-making.

Beyond Sonova, Rihs diversified his wealth by investing in private holdings. His ownership of Swiss Casinos AG, which operates four casinos in Switzerland, represents a move into the regulated gaming sector—a high-margin industry with significant barriers to entry. Similarly, his acquisition of BSC Young Boys, a Swiss soccer team, reflects an interest in sports and community engagement. While these ventures may not generate the same scale of revenue as Sonova, they contribute to his overall net worth and provide diversification benefits.

The path to wealth for Hans-Ueli Rihs is not the result of a single breakthrough or lucky investment but of sustained effort, strategic vision, and the ability to adapt to changing market conditions. His success is a testament to the power of long-term value creation, the importance of innovation in specialized industries, and the benefits of diversification. While the source material does not provide a detailed chronology of his career or personal milestones, the available information paints a clear picture of a billionaire whose wealth is rooted in the success of a global healthcare technology company and augmented by private holdings in entertainment and sports.

Hans-Ueli Rihs and his family preside over a tightly concentrated, vertically integrated empire anchored in Sonova — the global leader in hearing aids — and diversified into leisure and entertainment via Swiss Casinos AG and BSC Young Boys. This structure reflects a classic Swiss family holding model: core industrial asset generating stable cash flow, supplemented by high-margin, culturally embedded consumer assets. Sonova’s dominance — nearly $4B in FY2024 revenue — is not merely a function of scale but of proprietary technology, global distribution, and deep clinical relationships. The Rihs family’s 6% stake, while not controlling, is strategically positioned alongside Beda Diethelm, suggesting a coordinated governance approach that insulates the company from hostile takeovers while preserving operational autonomy. The empire’s durability hinges on the continued medicalization of hearing loss and the aging demographics of Western economies — trends that are structural, not cyclical.

Rihs’s leadership style is best described as low-profile, consensus-driven, and long-termist. Unlike flamboyant tech billionaires, he operates through institutional structures — boards, family trusts, and strategic partnerships — rather than personal charisma or media visibility. His collaboration with Beda Diethelm since the 1980s suggests a preference for shared stewardship over unilateral control. The death of his brother Andy in 2018 likely shifted internal dynamics, placing greater responsibility on Rihs to maintain continuity. His stewardship of BSC Young Boys — a club with deep national resonance — indicates an understanding of soft power and brand equity beyond pure financial return. This quiet, institutional approach reduces headline risk but may limit agility in fast-moving markets.

Capital allocation under Rihs has been conservative and focused: reinvestment in Sonova’s R&D and global footprint, selective acquisitions in adjacent health tech, and strategic diversification into regulated leisure (casinos) and cultural assets (soccer). The Swiss Casinos AG portfolio — four properties in a tightly regulated market — reflects a preference for stable, high-margin, non-cyclical cash flows. BSC Young Boys, while not a financial powerhouse, serves as a reputational anchor and community asset, enhancing brand loyalty and political goodwill. There is no evidence of aggressive leverage or speculative ventures; instead, the family appears to prioritize capital preservation and generational continuity. This approach insulates the empire from market volatility but may limit upside in high-growth sectors.

The primary risks to the Rihs empire are regulatory, reputational, and succession-related. Sonova operates in a heavily regulated healthcare space — subject to FDA, EMA, and national reimbursement policies — making it vulnerable to pricing controls and reimbursement cuts. The casino business faces increasing scrutiny over gambling addiction and money laundering, particularly as Switzerland tightens anti-gambling laws. BSC Young Boys, while culturally revered, carries reputational risk from fan violence, match-fixing allegations, or poor on-field performance. The family’s lack of public transparency — no formal succession plan, no detailed governance disclosures — creates uncertainty for investors and regulators. Concentration in a single industry (hearing aids) and geography (Switzerland) amplifies systemic risk, especially if demographic trends shift or disruptive technologies emerge.

Philanthropy under Rihs appears understated and locally focused, consistent with Swiss norms. While no major foundations or global initiatives are publicly linked to him, his ownership of BSC Young Boys functions as a form of civic philanthropy — supporting youth development, community cohesion, and national identity. Swiss Casinos AG likely contributes to local charities and cultural events, though details are not disclosed. This low-key approach avoids the scrutiny that accompanies high-profile giving but also limits the family’s ability to shape global narratives or influence policy. The absence of a formal philanthropic structure may become a liability as ESG expectations rise and stakeholders demand greater social accountability.

Rihs’s political influence is indirect but significant. Through Sonova, he wields soft power in healthcare policy circles, particularly in Switzerland and the EU, where hearing aid reimbursement and regulation are hotly debated. His ownership of BSC Young Boys grants him access to national political and cultural elites, while Swiss Casinos AG requires ongoing engagement with cantonal regulators. There is no evidence of direct lobbying or campaign contributions, suggesting influence is exercised through institutional channels — industry associations, advisory boards, and cultural patronage. This approach minimizes political risk but may limit the family’s ability to shape favorable regulatory outcomes in an increasingly polarized global environment.

The Rihs legacy is one of quiet industrial stewardship — transforming a mid-sized hearing aid manufacturer into a global healthcare leader while preserving family control and Swiss identity. Unlike dynasties built on finance or tech, the Rihs empire is rooted in tangible, socially valuable products — hearing aids that improve quality of life for millions. The challenge for the next generation is to maintain this legacy while adapting to digital health, AI-driven diagnostics, and global competition. The death of Andy Rihs in 2018 underscores the fragility of family-controlled empires; without a clear succession plan, the empire risks fragmentation or loss of strategic direction. The legacy will be judged not by wealth accumulation but by the durability of Sonova’s market position and the family’s ability to navigate generational transition.

• Profile: Hans-Ueli Rihs & family —
• Sonova Holding AG Annual Report FY2024
• SIX Swiss Exchange filings for Sonova
• Swiss Casinos AG corporate website and regulatory disclosures